EnteroMedics cuts R&D jobs
This article was originally published in Clinica
Executive Summary
Obesity treatment company EnteroMedics is to pare 13 jobs –nearly a fifth of its total workforce – from its R&D department, after having met several of its key clinical and product development objectives, thereby reducing the ongoing need to retain certain job functions.